Safety Study of IV Peramivir in Hospitalized Subjects With Confirmed or Suspected Influenza
Status:
Completed
Trial end date:
2011-08-01
Target enrollment:
Participant gender:
Summary
This is a Phase 3, open-label, randomized study of the antiviral activity, safety, and
tolerability of intravenous Peramivir in hospitalized subjects with confirmed or suspected
influenza infection.